Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Coronary Artery Calcification
100%
Complementary Role
100%
Coronary CT Angiography
100%
CVD Prevention
100%
Coronary Artery Disease
28%
Clinical High Risk
28%
Cardiovascular Risk
28%
Moderate Risk
28%
Zero Calcium Score
28%
High Risk
14%
Management Strategy
14%
Low Risk
14%
Statins
14%
Primary Prevention
14%
Cardiovascular Events
14%
Population-based Study
14%
Diabetes
14%
Non-diabetic
14%
High Prevalence
14%
Chest Pain
14%
Emergency Department
14%
Event-free Survival
14%
Progression Rate
14%
Prospective Cohort Study
14%
Large-scale Clinical Trial
14%
Cardiac Events
14%
Patient Assessment
14%
Prediction Method
14%
Risk Estimation
14%
Cardiovascular Prevention
14%
Scoring Method
14%
Risk Assessment
14%
Risk Category
14%
Reclassification
14%
Short-term Risk
14%
Diagnostic Work-up
14%
Risk Factor Assessment
14%
Risk Scoring
14%
Multi-population
14%
Unanswered Questions
14%
Practice Guidelines
14%
Preventative Medicine
14%
Cardiovascular Risk Assessment
14%
Preventive Practices
14%
UK Practice
14%
Medicine and Dentistry
Coronary Artery Calcification
100%
Cardiovascular System
42%
Coronary Artery Disease
28%
Isotopes of Calcium
28%
Clinical Trial
14%
Diabetes
14%
Prevalence
14%
Thorax Pain
14%
Cardiovascular Disease
14%
Cardiovascular Risk
14%
Statin
14%
Primary Prevention
14%
Event Free Survival
14%
Prospective Cohort Study
14%
Emergency Department
14%
Assessment Factor
14%
Nursing and Health Professions
Coronary Artery Calcification
100%
Imaging
28%
Coronary Artery Disease
28%
Prevalence
14%
Thorax Pain
14%
Cardiovascular Disease
14%
Practice Guideline
14%
Cardiac Event
14%
Cardiovascular Risk
14%
Event Free Survival
14%
Primary Prevention
14%
Statin (Protein)
14%
Prospective Cohort Study
14%
Adherence
14%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Calcification
100%
Coronary Artery Disease
28%
Clinical Trial
14%
Thorax Pain
14%
Cardiovascular Disease
14%
Cardiovascular Risk
14%
Statin (Protein)
14%
Prevalence
14%
Event Free Survival
14%
Prospective Cohort Study
14%
Assessment Factor
14%